• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Nascentia Health Enhances Aging in Place with Biofourmis’ Connected Care Platform

by Jasmine Pennic 12/15/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Nascentia Health, a provider of in-home care and insurance services in Central New York, is taking care-at-home to the next level with a strategic partnership with Biofourmis, a global leader in technology-enabled care delivery.

– The strategic collaboration aims to empower older adults to age safely and comfortably in their own homes while reducing unnecessary hospital readmissions and improving overall healthcare outcomes.

Key Benefits of the Partnership

– Reduced Hospital Readmissions and Length of Stay: Biofourmis’ connected platform will help Nascentia Health deliver more effective care management, leading to better patient outcomes and a reduction in costly hospital readmissions and extended hospital stays.

– Higher Patient Acuity and Multi-Disease Support: The platform’s flexibility and advanced capabilities will allow Nascentia Health to safely manage patients with multiple chronic conditions and higher acuity levels in the comfort of their own homes.

– Seamless Transition from Hospital to Home: Biofourmis’ technology will provide additional monitoring, support, and tasks, ensuring a smooth and comfortable transition for patients moving from hospital care back to their homes.

– Expanding Care-at-Home Offerings: Nascentia Health plans to leverage the Biofourmis platform to launch new care-at-home programs, starting with hospital-level care, followed by early-discharge services and chronic condition management.

Partnership Impact

This partnership aligns with the growing desire of older adults to age in place, as evidenced by the 2022 University of Michigan National Poll on Healthy Aging, which found that 88% of adults ages 50-80 want to stay in their homes as long as possible. Biofourmis’ technology, coupled with Nascentia Health’s extensive experience and expertise, has the potential to revolutionize care-at-home for older adults in Central New York and beyond.

“Tech-enabled care-at-home is helping achieve clinical and economic goals across the healthcare ecosystem and patients have consistently reported high satisfaction levels from routine virtual visits all the way up to hospital-level care,” said Maulik Majmudar, MD, Biofourmis chief medical officer and co-founder. “We are looking forward to supporting Nascentia Health as it expands its outstanding care-at-home services through our flexible, scalable market-leading solution that will enable more patients to receive high-quality care and stay healthier longer in the place they want to be.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Aging Care, Biofourmis

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |